×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Cardiopulmonary Exercise Testing Market

ID: MRFR/HC/51056-HCR
200 Pages
Rahul Gotadki
October 2025

India Cardiopulmonary Exercise Testing Market Research Report By Product (CPET Metabolic Carts, Software) and By End User (Hospitals and amp; Clinics, Diagnostic Centers, Ambulatory Centers, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Cardiopulmonary Exercise Testing Market Infographic
Purchase Options

India Cardiopulmonary Exercise Testing Market Summary

As per Market Research Future analysis, the India Cardiopulmonary Exercise Testing Market size was estimated at 60.0 USD Million in 2024. The Cardiopulmonary Exercise-testing market is projected to grow from 64.37 USD Million in 2025 to 130.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The India cardiopulmonary exercise-testing market is poised for substantial growth driven by technological advancements and increasing health awareness.

  • Technological advancements are enhancing the accuracy and efficiency of cardiopulmonary exercise testing devices.
  • The largest segment in the market is the diagnostic testing segment, while the fastest-growing segment is preventive healthcare services.
  • Increased health awareness among the population is driving demand for cardiopulmonary exercise testing as a preventive measure.
  • Rising incidence of cardiovascular diseases and advancements in medical technology are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 60.0 (USD Million)
2035 Market Size 130.0 (USD Million)
CAGR (2025 - 2035) 7.28%

Major Players

Cardinal Health (US), Philips (NL), GE Healthcare (US), Schiller AG (CH), MediSoft (FR), COSMED (IT), KORR Medical Technologies (US), Bodystat (GB)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

India Cardiopulmonary Exercise Testing Market Trends

The India Cardiopulmonary Exercise Testing Market is experiencing notable growth, driven by an increasing awareness of cardiovascular health and the rising prevalence of respiratory diseases. Healthcare professionals are increasingly recognizing the importance of exercise testing in diagnosing and managing various cardiopulmonary conditions. This trend is further supported by advancements in technology, which have led to the development of more sophisticated and user-friendly testing equipment. As a result, healthcare facilities are more inclined to adopt these innovative solutions, enhancing patient care and outcomes. Moreover, the emphasis on preventive healthcare is shaping the cardiopulmonary exercise-testing market. With a growing focus on early detection and intervention, healthcare providers are integrating exercise testing into routine assessments. This shift is likely to encourage more individuals to undergo testing, thereby expanding the market. Additionally, government initiatives aimed at promoting cardiovascular health and funding for research in this area are expected to bolster the market's growth. Overall, the cardiopulmonary exercise-testing market appears poised for continued expansion, driven by technological advancements and a heightened focus on preventive healthcare.

Technological Advancements

Recent innovations in cardiopulmonary exercise-testing equipment are enhancing the accuracy and efficiency of tests. Newer devices are more portable and user-friendly, allowing for easier integration into clinical settings. This trend is likely to encourage more healthcare providers to adopt advanced testing solutions.

Increased Health Awareness

There is a growing awareness among the population regarding the importance of cardiovascular health. This heightened consciousness is leading to more individuals seeking cardiopulmonary exercise testing as a preventive measure. Consequently, healthcare providers are responding by offering more comprehensive testing services.

Government Initiatives

Government programs aimed at improving public health are playing a crucial role in promoting cardiopulmonary exercise testing. Initiatives focused on cardiovascular health education and funding for related research are expected to drive market growth, making testing more accessible to the general population.

India Cardiopulmonary Exercise Testing Market Drivers

Growing Geriatric Population

India's aging population is a significant factor influencing the cardiopulmonary exercise-testing market. With an estimated 10% of the population aged 60 and above, the demand for health assessments tailored to older adults is increasing. This demographic is particularly susceptible to cardiopulmonary conditions, necessitating regular monitoring and evaluation. The cardiopulmonary exercise-testing market is likely to benefit from this trend, as healthcare providers seek to implement routine testing for early detection of potential health issues. Additionally, the rise in lifestyle-related diseases among the elderly population further emphasizes the need for effective diagnostic tools. As healthcare systems adapt to cater to the needs of older adults, the cardiopulmonary exercise-testing market is expected to expand, providing essential services to this growing segment.

Advancements in Medical Technology

Technological innovations in medical devices are transforming the cardiopulmonary exercise-testing market. The introduction of advanced testing equipment, such as portable and user-friendly devices, enhances the accessibility and efficiency of cardiopulmonary assessments. These innovations allow for more accurate measurements of oxygen uptake, heart rate, and other vital parameters during exercise testing. As a result, healthcare professionals can make more informed decisions regarding patient care. The market is projected to grow as hospitals and clinics invest in state-of-the-art technology to improve diagnostic capabilities. Moreover, the integration of telemedicine with exercise testing is emerging, enabling remote monitoring of patients' cardiopulmonary health. This shift could potentially expand the market's reach, particularly in rural areas where access to healthcare facilities is limited.

Expansion of Healthcare Infrastructure

The ongoing expansion of healthcare infrastructure in India is a crucial driver of the cardiopulmonary exercise-testing market. With the government and private sector investing in new hospitals and diagnostic centers, access to advanced medical services is improving. This development is particularly relevant for cardiopulmonary exercise testing, as more facilities are equipped with the necessary technology to conduct these assessments. The increase in healthcare facilities is likely to lead to a higher volume of tests being performed, thereby boosting market growth. Additionally, the establishment of specialized cardiology and pulmonary care centers is expected to enhance the quality of care provided to patients. As the healthcare landscape evolves, the cardiopulmonary exercise-testing market is poised to benefit from these infrastructural advancements.

Increased Focus on Preventive Healthcare

The shift towards preventive healthcare in India is driving the cardiopulmonary exercise-testing market. As individuals become more health-conscious, there is a growing emphasis on early detection and prevention of diseases. Cardiopulmonary exercise testing serves as a valuable tool in identifying potential health risks before they escalate into serious conditions. This proactive approach is gaining traction among healthcare providers, who are increasingly recommending exercise testing as part of routine health assessments. The market is likely to see growth as more individuals seek these tests to monitor their cardiovascular and pulmonary health. Furthermore, public health campaigns promoting the benefits of regular exercise and health screenings are expected to contribute to the market's expansion, as awareness of preventive measures continues to rise.

Rising Incidence of Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases in India is a primary driver for the cardiopulmonary exercise-testing market. According to recent health reports, cardiovascular diseases account for approximately 28% of all deaths in the country. This alarming statistic has led to a heightened demand for diagnostic tools that can assess heart and lung function effectively. As healthcare providers seek to implement preventive measures, the cardiopulmonary exercise-testing market is likely to experience significant growth. The ability of these tests to provide critical insights into a patient's cardiovascular health makes them indispensable in clinical settings. Furthermore, the integration of exercise testing in routine health check-ups is becoming more common, thereby expanding the market's reach. This trend suggests that the cardiopulmonary exercise-testing market will continue to thrive as awareness of cardiovascular health issues grows.

Market Segment Insights

By Product Type: CPET Metabolic Carts (Largest) vs. Software (Fastest-Growing)

The India cardiopulmonary exercise-testing market exhibits a diverse landscape dominated by CPET metabolic carts, which hold the largest market share due to their widespread application in clinical diagnostics and research. Their reliability and extensive features make them essential for accurate cardiopulmonary assessments. Conversely, software solutions have emerged with a significant presence, catering to the growing need for data management and analysis in exercise testing, thus contributing to an expanding niche in the market. Looking at growth trends, software is recognized as the fastest-growing segment, driven by advancements in technology and increasing demand for intuitive data analysis tools. This trend is fueled by healthcare providers seeking to enhance the efficiency of testing processes and improve patient care outcomes. With the integration of AI and machine learning in software solutions, the market is expected to experience robust growth as facilities upgrade their equipment and capabilities.

CPET Metabolic Carts (Dominant) vs. Software (Emerging)

CPET metabolic carts are critical in the diagnostic framework, providing comprehensive data on respiratory and cardiovascular performance. These devices are characterized by their advanced functionalities, allowing for a thorough analysis of exercise capacity and physiological response. Their established use in hospitals and sports medicine centers positions them as the dominant force in the market. On the other hand, software solutions represent an emerging trend, offering innovative ways to manage and interpret data generated from exercise tests. Their ability to integrate with existing hardware and provide real-time analytics makes them increasingly attractive to healthcare professionals, driving growth in this sector as organizations strive for improved data utilization and streamlined workflows.

By End User: Hospitals & Clinics (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the India cardiopulmonary exercise-testing market, Hospitals & Clinics command a significant share, leveraging their extensive infrastructures and access to advanced technologies. This segment remains the largest, catering to a vast patient base and offering a wide range of cardiopulmonary diagnostic services. Diagnostic Centers, while smaller in market share, are rapidly gaining prominence due to their focus on specialized tests and convenience, contributing substantially to the overall market dynamic. Growth trends in this segment are driven by increasing awareness of cardiovascular health and rising incidences of related diseases. The expansion of Diagnostic Centers can be attributed to their ability to offer targeted testing and shorter waiting times, which appeal to patients seeking efficiency. Meanwhile, Hospitals & Clinics continue to innovate and integrate advanced exercise testing technologies, solidifying their dominant position while adapting to emerging healthcare trends.

Hospitals & Clinics (Dominant) vs. Diagnostic Centers (Emerging)

Hospitals & Clinics serve as the cornerstone of the India cardiopulmonary exercise-testing market, providing comprehensive cardiovascular services supported by skilled healthcare professionals and advanced technologies. They are equipped to handle complex cases and often lead in innovations such as telemedicine and remote monitoring. In contrast, Diagnostic Centers are emerging as pivotal players, focusing on specialized cardiopulmonary testing that emphasizes convenience and efficiency. These centers are attracting patients with streamlined processes and reduced turnaround times for test results. Together, they create a robust ecosystem that enhances patient access to essential cardiopulmonary health services, responding to the growing demand for timely and accurate diagnostics.

Get more detailed insights about India Cardiopulmonary Exercise Testing Market

Key Players and Competitive Insights

The cardiopulmonary exercise-testing market is currently characterized by a dynamic competitive landscape, driven by increasing health awareness and the rising prevalence of cardiovascular diseases. Key players such as Cardinal Health (US), Philips (NL), and GE Healthcare (US) are strategically positioned to leverage innovation and technological advancements. Cardinal Health (US) focuses on enhancing its product offerings through continuous research and development, while Philips (NL) emphasizes digital transformation and integrated solutions to improve patient outcomes. GE Healthcare (US) is also investing in advanced analytics and AI to optimize its cardiopulmonary testing solutions, thereby shaping a competitive environment that prioritizes technological superiority and patient-centric approaches.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they set industry standards and drive innovation. This competitive structure suggests that while there is room for smaller players, the dominance of established firms is likely to shape market dynamics in the foreseeable future.

In October Philips (NL) announced a strategic partnership with a leading Indian healthcare provider to enhance its cardiopulmonary exercise-testing capabilities. This collaboration aims to integrate advanced digital health solutions into existing healthcare frameworks, thereby improving accessibility and efficiency in patient care. The strategic importance of this partnership lies in its potential to expand Philips' market reach while addressing local healthcare challenges through tailored solutions.

In September GE Healthcare (US) launched a new line of cardiopulmonary exercise-testing equipment designed to incorporate AI-driven analytics. This innovation is expected to enhance diagnostic accuracy and streamline workflow in clinical settings. The introduction of AI capabilities signifies a critical shift towards data-driven decision-making in healthcare, positioning GE Healthcare as a leader in technological advancement within the market.

In August Cardinal Health (US) expanded its distribution network in India, focusing on improving supply chain logistics for cardiopulmonary testing equipment. This move is likely to enhance product availability and reduce lead times, thereby strengthening Cardinal Health's competitive position. The expansion reflects a broader trend of companies optimizing their supply chains to meet growing demand in emerging markets.

As of November current competitive trends in the cardiopulmonary exercise-testing market include a strong emphasis on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition towards a focus on technological innovation, reliability in supply chains, and enhanced patient outcomes. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge.

Key Companies in the India Cardiopulmonary Exercise Testing Market include

Industry Developments

The India Cardiopulmonary Exercise Testing Market has witnessed several significant developments recently. In October 2023, Philips Healthcare launched advanced cardiopulmonary exercise testing equipment aimed at enhancing diagnosis and treatment options for patients with heart and lung diseases in India. In response to increasing demand, TruCo has expanded its product range to include portable CPET devices, which have gained popularity among clinicians for outpatient settings. Furthermore, in late 2022, Geratherm Medical AG strengthened its position in the Indian market by introducing a new line of non-invasive respiratory monitoring devices, complementing its existing CPET solutions.

Industry growth is being driven by rising awareness of cardiovascular diseases and the importance of non-invasive testing methods. 

The Indian government's initiatives to enhance healthcare infrastructure, particularly in rural areas, are also facilitating the adoption of advanced cardiopulmonary exercise testing technologies. Notably, the American Heart Association has been actively collaborating with local institutions to improve training and certification in cardiopulmonary exercise testing, ensuring that healthcare professionals are equipped with the necessary skills for effective patient assessment. Overall, these developments reflect a dynamic and evolving landscape in India's Cardiopulmonary Exercise Testing Market, supported by innovation and strategic collaborations among key players.

Future Outlook

India Cardiopulmonary Exercise Testing Market Future Outlook

The Cardiopulmonary Exercise Testing Market is projected to grow at 7.28% CAGR from 2025 to 2035, driven by technological advancements, increasing health awareness, and rising chronic diseases.

New opportunities lie in:

  • Development of portable exercise testing devices for home use.
  • Integration of AI analytics for personalized exercise prescriptions.
  • Expansion of telehealth services for remote cardiopulmonary assessments.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand.

Market Segmentation

India Cardiopulmonary Exercise Testing Market End User Outlook

  • Hospitals & Clinics
  • Diagnostic Centers
  • Ambulatory Centers
  • Others

India Cardiopulmonary Exercise Testing Market Product Type Outlook

  • CPET metabolic carts
  • software

Report Scope

MARKET SIZE 2024 60.0(USD Million)
MARKET SIZE 2025 64.37(USD Million)
MARKET SIZE 2035 130.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.28% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Cardinal Health (US), Philips (NL), GE Healthcare (US), Schiller AG (CH), MediSoft (FR), COSMED (IT), KORR Medical Technologies (US), Bodystat (GB)
Segments Covered Product Type, End User
Key Market Opportunities Integration of advanced wearable technology enhances patient monitoring in the cardiopulmonary exercise-testing market.
Key Market Dynamics Rising demand for advanced cardiopulmonary exercise-testing technologies driven by regulatory changes and healthcare consumer preferences.
Countries Covered India
Leave a Comment

FAQs

What is the expected market size of the India Cardiopulmonary Exercise Testing Market in 2024?

The India Cardiopulmonary Exercise Testing Market is expected to be valued at 60.0 USD Million in 2024.

What is the projected market size of the India Cardiopulmonary Exercise Testing Market by 2035?

By 2035, the market is projected to reach a valuation of 160.0 USD Million.

What is the anticipated CAGR for the India Cardiopulmonary Exercise Testing Market between 2025 and 2035?

The market is expected to grow at a CAGR of 9.326% from 2025 to 2035.

Which product segment holds the largest share in the India Cardiopulmonary Exercise Testing Market?

The CPET Metabolic Carts segment is expected to dominate the market with a value of 36.0 USD Million in 2024.

What will be the market value of the Software segment by 2035?

The Software segment is projected to reach a value of 64.0 USD Million by 2035.

Who are the key players in the India Cardiopulmonary Exercise Testing Market?

Major players include TruCo, Geratherm Medical AG, Cosmed, and Philips Healthcare among others.

What growth opportunities exist in the India Cardiopulmonary Exercise Testing Market?

There are significant growth opportunities driven by advances in technology and increasing prevalence of cardiovascular diseases.

What challenges does the India Cardiopulmonary Exercise Testing Market currently face?

The market faces challenges such as the high cost of equipment and varying regulations across regions.

How does the market growth rate vary by product segment?

The CPET Metabolic Carts segment is expected to have a substantial growth rate compared to the Software segment.

What impact does regionality have on the growth of the India Cardiopulmonary Exercise Testing Market?

Regional variations in healthcare infrastructure and awareness significantly influence market growth across different areas.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions